LG Chem announced on the 28th that it has signed a contract with Kyowa Kirin Korea to jointly sell two drugs, Nesp(Darbepoetin Alfa) and Regpara (Cinacalcet Hydrochloride)' in Korea. LG Chem is in charge of sales at the clinics level, and Kyowa Kirin Korea is in charge of sales at the general hospital level. Nesp is a continuous hematopoietic agent used to treat anemia in patients with chronic kidney disease. It is prescribed for hemodialysis or peritoneal dialysis patients or patients with chronic kidney disease before dialysis. LG Chem explains that treatment is highly convenient because it only needs to be administered once every one to two weeks.

Since its release in South Korea in 2010, it has been